Graham Reeve - Aug 9, 2021 Form 4 Insider Report for U S PHYSICAL THERAPY INC /NV (USPH)

Role: COO
Signature: /s/ Graham D Reeve
Stock symbol: USPH
Transactions as of: Aug 9, 2021
Transactions value $: -$177,960
Form type: 4
Date filed: 8/10/2021, 06:23 PM
Previous filing: May 10, 2021
Next filing: Dec 7, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	USPH	Common Stock	Sale	-$178K	-1.56K	-18.35%	$114.15	6.94K	Aug 9, 2021	Reeve Trust	F2
holding	USPH	Common Stock						14.1K	Aug 9, 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 14,126 shares which restrictions lapse as to 1,909 shares on October 1, 2021; 1,912 shares on January 1, 2022; 1,433 on each of April 1, July 1 and October 1, 2022; 1,448 shares on January 1, 2023; 788 shares on each of April 1, July 1 and October 1, 2023; 794 shares on January 1, 2024; and 350 shares on each of April 1, July 1 and October 1, 2024 and January 1, 2025, if he is employed by the Company on those dates.
F2	The price reported is a weighted average price ($114.15). The shares were sold in multiple transactions at prices ranging from $113.96 to $114.42 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Content

Includes 14,126 shares which restrictions lapse as to 1,909 shares on October 1, 2021; 1,912 shares on January 1, 2022; 1,433 on each of April 1, July 1 and October 1, 2022; 1,448 shares on January 1, 2023; 788 shares on each of April 1, July 1 and October 1, 2023; 794 shares on January 1, 2024; and 350 shares on each of April 1, July 1 and October 1, 2024 and January 1, 2025, if he is employed by the Company on those dates.

The price reported is a weighted average price ($114.15). The shares were sold in multiple transactions at prices ranging from $113.96 to $114.42 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.